|
|||||
|
|
An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients. |
|
| Authors: | Anne-Marie O'Farrell James M Foran Walter Fiedler Hubert Serve Ron L Paquette Maureen A Cooper Helene A Yuen Sharianne G Louie Heidi Kim Susan Nicholas Michael C Heinrich Wolfgang E Berdel Carlo Bello Mark Jacobs Paul Scigalla William C Manning Stephen Kelsey Julie M Cherrington |
| Institution: | SUGEN Inc., South San Francisco, California, USA. marie@ceolas.org |
| Abstract: | |
| Keywords: | |